- Report
- April 2018
United States
From €7276EUR$7,995USD£6,238GBP
- Report
- September 2022
- 86 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- September 2023
- 89 Pages
Global
From €3500EUR$4,120USD£3,106GBP
- Report
- October 2024
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- April 2023
- 263 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- June 2022
- 230 Pages
Global
From €3145EUR$3,456USD£2,696GBP
- Report
- January 2022
- 220 Pages
Global
From €3378EUR$3,712USD£2,896GBP
Methotrexate is a drug used to treat immune disorders, such as rheumatoid arthritis, psoriasis, and Crohn's disease. It works by blocking the action of an enzyme involved in the production of certain proteins that are necessary for the growth and development of cells. It is also used to treat certain types of cancer. Methotrexate is available in both oral and injectable forms.
Methotrexate is a widely used drug in the treatment of immune disorders. It is generally well tolerated and has been shown to be effective in reducing symptoms and improving quality of life. It is also used in combination with other drugs to treat more severe cases of immune disorders.
The market for Methotrexate is highly competitive, with many companies offering different formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, and AbbVie. Show Less Read more
